[Hopespringpcsg] FW: The Prostate Cancer InfoLink

[Glen Tolhurst]

If J & J, parent of Janssen, loses the appeal of this cash cow ($5K/patient/month), will it impact Janssen support of PCCN chapters?

 



 <https://prostatecancerinfolink.net> The Prostate Cancer InfoLink 

	
  _____  


 <http://feedproxy.google.com/~r/TheProstateCancerInfolink/~3/UjjTiq7_pd0/?utm_source=feedburner&utm_medium=email> Might we see generic abiraterone acetate this year? 

Posted: 18 Jan 2018 10:52 AM PST

On Wednesday the U.S. Patent Trial and Appeal Board invalidated the last remaining patent on abiraterone acetate (Zytiga), making it possible that generic forms of abiraterone acetate would be available in 2018 (at least in the US). We can expect Johnson & Johnson to appeal this decision, so the early availability of generic abiraterone acetate […]

 


You are subscribed to email updates from THE  <https://prostatecancerinfolink.net> "NEW" PROSTATE CANCER INFOLINK.



Email delivery powered by Google

	

 

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20180119/48ce8ec5/attachment.html>